Another study found that macrophages are the dominant cells regulating the inflammatory milieu of the MM niche; inhibition of TPL2 kinase in macrophages leads to inhibition of interleukin (IL)-1β and IL-6, ultimately resulting in myeloma progression [73]. This evidence concerns the gene IL6 and Miyoshi myopathy.